Malignant Solid Tumor
📧 Sign up to get email alerts when something new happens for Malignant Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-11Clinical Trial Results: Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating GEN1055 as monotherapy and in combination for malignant solid tumors has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Studying TAK-243 in Patients With Advanced Cancer [Phase 1]
This entry describes a Phase 1 clinical trial evaluating TAK-243 in adults with advanced cancers, including non-Hodgkin lymphoma and various…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors [Phase 1, Phase 2]
GEN1042 is being evaluated in a Phase 1/2 safety study with indications across malignant solid tumors, including non-small cell lung cancer,…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy [Phase 1, Phase 2]
The Phase 1/2 trial evaluating the safety and preliminary efficacy of GEN1055 in malignant solid tumors (as monotherapy and in combination) …
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K) [Phase 2]
This Clinical Trial Update reports that ipatasertib is being tested as a targeted therapy for cancers with AKT genetic alterations in the NC…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors [NA]
This ClinicalTrials.gov update reports completion of an investigational 7T MRI imaging study for central nervous system tumors, with results…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Viral Specific T Cell Therapy for COVID-19 Related Pneumonia [EARLY_Phase 1]
An early Phase 1 trial of viral-specific T cell therapy for COVID-19-related pneumonia has completed, evaluating safety and feasibility in p…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of methoxyamine with cisplatin and pemetrexed disodium in patients with advanced solid tumors or …
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors. [Phase 1, Phase 2]
A first-in-human trial update evaluating IAE0972 in patients with advanced malignant solid tumors (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Open-label, multicenter Phase 1/2 trial evaluating PARP inhibitor E7449 as a single agent and in combination regimens for advanced solid tum…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors [Phase 1, Phase 2]
A clinical trial update for ScTIL210 assessing safety and efficacy in malignant solid tumors (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab [Phase 1, Phase 2]
Phase 1/2 trial update for experimental immunotherapy BMS-986179, studied alone and with nivolumab, in malignant solid tumors; results poste…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor [Phase 1, Phase 2]
Clinical trial update reporting phase 1/2 study on comprehensive treatment for malignant solid tumors; the study is completed.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study [Phase 1, Phase 2]
Clinical trial updates for CD24Fc (TIRAEC study) in advanced solid tumors show termination after Phase 1/2 with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies [Phase 2]
An extension study of NKTR-102 in cancer patients previously enrolled in NKTR-102 studies (Phase 2) has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating enzastaurin plus erlotinib in solid tumors and non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R) [Phase 2]
The National Cancer Institute’s MATCH subprotocol R Phase 2 trial is evaluating trametinib as a targeted therapy for cancers with BRAF genet…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies [Phase 1, Phase 2]
Phase 1/2 trial of eribulin with cyclophosphamide in malignant solid tumors and metastatic/recurrent breast cancer; study completed with res…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan [Phase 1]
Phase I trial update for ONO-4538 in patients with advanced malignant solid tumors conducted in Japan; results completed with results posted…
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial investigating bevacizumab combined with allogeneic NK immunotherapy in malignant solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating combination of anti-PD-1 therapy with NK cell–based immunotherapy for recurrent malignant solid tumors.
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread [Phase 1]
Phase 1 trial update for LY2334737 in advanced/metastatic cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Safety and Bioimaging Trial of DS-8895a in Patients With Advanced EphA2 Positive Cancers [Phase 1]
Phase 1 safety and bioimaging trial of DS-8895a in patients with advanced EphA2-positive cancers completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation
A completed clinical trial update assessing physical fitness in cancer patients using cardiopulmonary exercise testing and wearable data gen…
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin [Phase 2]
Phase 2 trial update evaluating necitumumab in combination with gemcitabine-cisplatin for malignant solid tumors.